EDIROL Drug Intensive Monitoring: Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis
Latest Information Update: 30 Jun 2022
At a glance
- Drugs Eldecalcitol (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
Most Recent Events
- 30 Jun 2022 New trial record